Given that the previously published trial for IL18 inhibition in type 2 diabetes failed to demonstrate efficacy, we tested whether IL18 levels were causally associated with an increased risk of type 2 diabetes using the same MR methods described above. Here, IL18 is linked to type 2 diabetes mellitus.